Bibliography for Item 12 in BGP: Difference between revisions
| Line 1: | Line 1: | ||
==Resources== | ==Resources== | ||
What You Can Learn from Managers in Biotech | *Prewitt, Edward, ''What You Can Learn from Managers in Biotech'', Harvard Management Update, May 1 1997, | ||
http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=U9705A&_requestid=6230 | http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=U9705A&_requestid=6230 | ||
*Lakhani, Karim R. and Lars Bo Jeppesen, Peter A. Lohse and Jill A. Panetta, ''The Value of Openness in Scientific Problem Solving'', Technology and Operations Management, No. 07-050, January 2007. | |||
**Complete Text (Acrobat PDF Version) Openness and free information sharing amongst scientists are supposed to be core norms of the scientific community. However, many studies have shown that these norms are not universally followed. Lack of openness and transparency means that scientific problem solving is constrained to a few scientists who work in secret and who typically fail to leverage the entire accumulation of scientific knowledge available. We present evidence of the efficacy of problem solving when disclosing problem information. The method’s application to 166 discrete scientific problems from the research laboratories of 26 firms is illustrated. Problems were disclosed to over 80,000 independent scientists from over 150 countries. We show that disclosure of problem information to a large group of outside solvers is an effective means of solving scientific problems. The approach solved one-third of a sample of problems that large and well-known R & D-intensive firms had been unsuccessful in solving internally. Problem-solving success was found to be associated with the ability to attract specialized solvers with range of diverse scientific interests. Furthermore, successful solvers solved problems at the boundary or outside of their fields of expertise, indicating a transfer of knowledge from one field to others. | |||
Karim R. | |||
Technology and Operations Management | |||
January 2007 | |||
Complete Text (Acrobat PDF Version) Openness and free information sharing amongst scientists are supposed to be core norms of the scientific community. However, many studies have shown that these norms are not universally followed. Lack of openness and transparency means that scientific problem solving is constrained to a few scientists who work in secret and who typically fail to leverage the entire accumulation of scientific knowledge available. We present evidence of the efficacy of problem solving when disclosing problem information. The method’s application to 166 discrete scientific problems from the research laboratories of 26 firms is illustrated. Problems were disclosed to over 80,000 independent scientists from over 150 countries. We show that disclosure of problem information to a large group of outside solvers is an effective means of solving scientific problems. The approach solved one-third of a sample of problems that large and well-known R & D-intensive firms had been unsuccessful in solving internally. Problem-solving success was found to be associated with the ability to attract specialized solvers with range of diverse scientific interests. Furthermore, successful solvers solved problems at the boundary or outside of their fields of expertise, indicating a transfer of knowledge from one field to others. | |||
58 pages | 58 pages | ||
The Life Sciences Revolution: A Technical Primer | Pisano, Gary P., Stephanie Oestreich, Clarissa Ceruti, ''The Life Sciences Revolution: A Technical Primer'', January 28, 2002 | ||
http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=602118&_requestid=6269 | http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=602118&_requestid=6269 | ||
Innovation and Leadership Values | Miles, Raymond, ''Innovation and Leadership Values'', November 1, 2007, | ||
http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=CMR385&_requestid=7630 | http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=CMR385&_requestid=7630 | ||
Learning From Collaboration: Knowledge and Networks in the Biotechnology and Pharmaceutical Industries | Powell, Walter, ''Learning From Collaboration: Knowledge and Networks in the Biotechnology and Pharmaceutical Industries'', CMR April 1, 2008 | ||
http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=CMR117&_requestid=5010 | http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=CMR117&_requestid=5010 | ||
The Performance of the Biotech Industry: Promise Versus Reality | Pisano, Gary P., ''The Performance of the Biotech Industry: Promise Versus Reality'', HBS Press Chapter, November 14, 2006, | ||
http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=6608BC&_requestid=5019 | http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=6608BC&_requestid=5019 | ||
The Monetization of Intellectual Property: The Forces that Drive the Business of Biotechnology | Pisano, Gary P., ''The Monetization of Intellectual Property: The Forces that Drive the Business of Biotechnology'', HBS Press Chapter, November 14, | ||
http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=6609BC&_requestid=5023 | http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=6609BC&_requestid=5023 | ||
The Science-Based Business: A Novel Experiment | Pisano, Gary P., ''The Science-Based Business: A Novel Experiment'', HBS Press Chapter, November 14, http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=6534BC&_requestid=5539 | ||
http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=6534BC&_requestid=5539 | |||
(I have this Pisano's book - Science Business...It is worth reading to find information about the field) | (I have this Pisano's book - Science Business...It is worth reading to find information about the field) | ||
''Brendan: got it from the library. very helpful'' | |||
<br> | |||
Lehrer, Mark, ''Kazuhiro Asakawa Pushing Scientists into the Marketplace: Promoting Science Entrepreneurship'', CMR, May 1, 2004. http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=CMR284&_requestid=6247 | |||
Binder, Gordon, Philip Bashe ''Science Lessons: What the Business of Biotech Taught Me About Management'', Cambridge: Harvard Business School Press, 2008. http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=8614&_requestid=6530 | |||
Science Lessons: What the Business of Biotech Taught Me About Management | |||
http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=8614&_requestid=6530 | |||
The Pharma Giants: Ready for the 21st Century? | The Pharma Giants: Ready for the 21st Century? | ||
Revision as of 23:51, 15 March 2009
Resources
- Prewitt, Edward, What You Can Learn from Managers in Biotech, Harvard Management Update, May 1 1997,
- Lakhani, Karim R. and Lars Bo Jeppesen, Peter A. Lohse and Jill A. Panetta, The Value of Openness in Scientific Problem Solving, Technology and Operations Management, No. 07-050, January 2007.
- Complete Text (Acrobat PDF Version) Openness and free information sharing amongst scientists are supposed to be core norms of the scientific community. However, many studies have shown that these norms are not universally followed. Lack of openness and transparency means that scientific problem solving is constrained to a few scientists who work in secret and who typically fail to leverage the entire accumulation of scientific knowledge available. We present evidence of the efficacy of problem solving when disclosing problem information. The method’s application to 166 discrete scientific problems from the research laboratories of 26 firms is illustrated. Problems were disclosed to over 80,000 independent scientists from over 150 countries. We show that disclosure of problem information to a large group of outside solvers is an effective means of solving scientific problems. The approach solved one-third of a sample of problems that large and well-known R & D-intensive firms had been unsuccessful in solving internally. Problem-solving success was found to be associated with the ability to attract specialized solvers with range of diverse scientific interests. Furthermore, successful solvers solved problems at the boundary or outside of their fields of expertise, indicating a transfer of knowledge from one field to others.
58 pages
Pisano, Gary P., Stephanie Oestreich, Clarissa Ceruti, The Life Sciences Revolution: A Technical Primer, January 28, 2002 http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=602118&_requestid=6269
Miles, Raymond, Innovation and Leadership Values, November 1, 2007, http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=CMR385&_requestid=7630
Powell, Walter, Learning From Collaboration: Knowledge and Networks in the Biotechnology and Pharmaceutical Industries, CMR April 1, 2008 http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=CMR117&_requestid=5010
Pisano, Gary P., The Performance of the Biotech Industry: Promise Versus Reality, HBS Press Chapter, November 14, 2006, http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=6608BC&_requestid=5019
Pisano, Gary P., The Monetization of Intellectual Property: The Forces that Drive the Business of Biotechnology, HBS Press Chapter, November 14, http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=6609BC&_requestid=5023
Pisano, Gary P., The Science-Based Business: A Novel Experiment, HBS Press Chapter, November 14, http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=6534BC&_requestid=5539
(I have this Pisano's book - Science Business...It is worth reading to find information about the field)
Brendan: got it from the library. very helpful
Lehrer, Mark, Kazuhiro Asakawa Pushing Scientists into the Marketplace: Promoting Science Entrepreneurship, CMR, May 1, 2004. http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=CMR284&_requestid=6247
Binder, Gordon, Philip Bashe Science Lessons: What the Business of Biotech Taught Me About Management, Cambridge: Harvard Business School Press, 2008. http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=8614&_requestid=6530
The Pharma Giants: Ready for the 21st Century? http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=698070&_requestid=5868
Note on the Convergence Between Genomics & Information Technology http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=705500&_requestid=5904
Novartis-U.C. Berkeley Research Collaboration http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=BME7&_requestid=5636
Kevin Sharer at Amgen: Sustaining the High-Growth Company (A) http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=406020&referral=2342
Patent Sharks http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=R0806J&_requestid=6985
How to Get the Most From University Relationships http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=SMR282&_requestid=7622
Gilead Sciences https://gsbapps.stanford.edu/cases/detail1.asp?Document_ID=1357
Note On The Biopharmaceutical Industry https://gsbapps.stanford.edu/cases/detail1.asp?Document_ID=1785You probably can get this through your University. If you can't ask Roxy the favor of downloading this papers and sending to you. She is a RA in Aarons group that also work in HBS. Her email is "Roxanna Myhrum" < rmyhrum@cyber.law.harvard.edu> and "Roxanna Myhrum" <rox.myhrum@gmail.com>.
Open Business models in BGP
Biotechnology_-_Genomic_and_Proteomics